×
About 2,531 results

ALLMedicine Cardiovascular Risk Management Center

Research & Reviews  273 results

Obesity and cardiovascular risk management is a critical way to reduce healthcare resou...
https://doi.org/10.1177/2047487320929248
European Journal of Preventive Cardiology; Chen L, Hao G

Jun 1st, 2020 - Obesity and cardiovascular risk management is a critical way to reduce healthcare resource pressure.|2020|Chen L,Hao G,|

Repurposing Available Anti-inflammatory and Immunomodulating Agents for Cardiovascular ...
https://doi.org/10.2174/157488471501200319150358
Current Clinical Pharmacology; Mangoni AA, Erre GL

May 14th, 2020 - Repurposing Available Anti-inflammatory and Immunomodulating Agents for Cardiovascular Risk Management: A Call for Submissions to Current Clinical Pharmacology.|2020|Mangoni AA,Erre GL,|

Issues of Cardiovascular Risk Management in People With Diabetes in the COVID-19 Era.
https://doi.org/10.2337/dc20-0941
Diabetes Care; Ceriello A, Standl E et. al.

May 13th, 2020 - People with diabetes compared with people without exhibit worse prognosis if affected by coronavirus disease 2019 (COVID-19) induced by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), particularly when compromising metabolic cont...

Nonvalidated Home Blood Pressure Devices Dominate the Online Marketplace in Australia: ...
https://doi.org/10.1161/HYPERTENSIONAHA.120.14719
Hypertension (Dallas, Tex. : 1979); Picone DS, Deshpande RA et. al.

Apr 10th, 2020 - Self-home blood pressure (BP) monitoring is recommended to guide clinical decisions on hypertension and is used worldwide for cardiovascular risk management. People usually make their own decisions when purchasing BP devices, which can be made onl...

Strategies for implementation of guideline recommended cardiovascular risk management f...
https://doi.org/10.1007/s00296-020-04533-4
Rheumatology International; Weijers JM, Semb AG et. al.

Feb 23rd, 2020 - The aim was to study the different strategies used to implement cardiovascular risk evaluation and management for patients with rheumatoid arthritis (RA) in daily clinical practice. A questionnaire survey was performed among both the members of th...

see more →

Guidelines  5 results

2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduct...
http://www.onlinejacc.org/content/early/2018/11/23/j.jacc.2018.09.020

Nov 25th, 2018 - Despite major therapeutic advances leading to improved outcomes over the past 2 decades, cardiovascular (CV) disease remains the leading cause of morbidity and mortality in patients with type 2 diabetes (T2D) (1). Over that time, the prevalence of.

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of ...
http://www.onlinejacc.org/content/early/2018/11/02/j.jacc.2018.11.003
Grundy, S.,et al

Nov 9th, 2018 - The recommendations listed in the present guideline are, whenever possible, evidence based. An initial extensive evidence review, which included literature derived from research involving human subjects, published in English, and indexed in MEDLIN.

Cardiovascular Disease and Risk Management: Standards of Medical Care in Diabetes—2018
http://care.diabetesjournals.org/lookup/doi/10.2337/dc18-S009
American Diabetes Association

Dec 31st, 2017 - Atherosclerotic cardiovascular disease (ASCVD)—defined as coronary heart disease, cerebrovascular disease, or peripheral arterial disease presumed to be of atherosclerotic origin—is the leading cause of morbidity and mortality for individuals with.

2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Sta...
http://www.onlinejacc.org/content/early/2017/08/30/j.jacc.2017.07.745
Lloyd-Jones, D.,et al.

Sep 4th, 2017 - In 2016, the American College of Cardiology published the first expert consensus decision pathway (ECDP) on the role of non-statin therapies for low-density lipoprotein (LDL)–cholesterol lowering in the management of atherosclerotic cardiovascular.

EULAR evidence-based recommendations for cardiovascular risk management in patients wit...
https://doi.org/10.1136/ard.2009.113696
Annals of the Rheumatic Diseases; Peters MJ, Symmons DP et. al.

Sep 23rd, 2009 - To develop evidence-based EULAR recommendations for cardiovascular (CV) risk management in patients with rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA). A multidisciplinary expert committee was convened as a t...

see more →

Drugs  953 results see all →

Clinicaltrials.gov  1,265 results

Obesity and cardiovascular risk management is a critical way to reduce healthcare resou...
https://doi.org/10.1177/2047487320929248
European Journal of Preventive Cardiology; Chen L, Hao G

Jun 1st, 2020 - Obesity and cardiovascular risk management is a critical way to reduce healthcare resource pressure.|2020|Chen L,Hao G,|

Prazosin hydrochloride - prazosin hydrochloride capsule-Major Pharmaceuticals
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=4f55f4db-dab3-4e50-9f71-5595fd3ccc12

Jun 1st, 2020 - Prazosin Hydrochloride Capsules, USP is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These...

Lisinopril and hydrochlorothiazide - lisinopril and hydrochlorothiazide tablet-Actavis Pharma, Inc.
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ab5e9ae4-e575-4a63-99f3-2bde36bdd508

May 25th, 2020 - Lisinopril and Hydrochlorothiazide Tablets is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions....

Prazosin hydrochloride - prazosin hydrochloride capsule-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=cbcaa806-883f-4496-865e-7710f547aeda

May 21st, 2020 - Prazosin hydrochloride capsules are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These ben...

Felodipine - felodipine tablet, film coated, extended release-Bryant Ranch Prepack
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=924b2633-74bd-469f-b831-77f09dfebbf7

May 21st, 2020 - Felodipine tablets are indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have be...

see more →

News  35 results

Treatment Tips as COVID-19 Complicates CVD Management in Diabetes
https://www.medscape.com/viewarticle/930994

May 21st, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape' Coronavirus Resource Center. A new article outlines the many ways in which the COVID-19 pandemic necessitates new considerations beyond traditional cardiovascular risk manageme...

Cardiovascular risk management supported for type 2 diabetes
https://www.mdedge.com/neurology/article/172877/mixed-topics/cardiovascular-risk-management-supported-type-2-diabetes

Aug 17th, 2018 - Two studies published in the New England Journal of Medicine support managing cardiovascular risk in patients with type 2 diabetes. Also today, spontaneous intracranial hypotension is a triple misnomer, prolonged antimalarial therapy is linked to.

Studies support cardiovascular risk management in T2DM
https://www.mdedge.com/familymedicine/article/172698/diabetes/studies-support-cardiovascular-risk-management-t2dm/page/0/1
Clinical Endocrinology News;

Aug 15th, 2018 - The second study, which included 271,174 patients with T2DM from the Swedish National Diabetes Register and 1,355,870 controls, examined five risk factors: elevated glycated hemoglobin level, elevated low-density lipoprotein cholesterol level, alb.

LDL particle number advantageous in managing cardiovascular risk
https://www.mdedge.com/internalmedicine/article/81826/cad-atherosclerosis/ldl-particle-number-advantageous-managing
Bruce Jancin

Apr 23rd, 2014 - WASHINGTON – High-risk patients managed to a target LDL particle number rather than to an LDL cholesterol goal had 25% fewer cardiovascular events over 3 years of follow-up. "These new data add to the growing body of evidence suggesting that [nucl.

Arthritis Plus Hypothyroidism Ups Women's CVD Risk
https://www.mdedge.com/rheumatology/article/48975/cad-atherosclerosis/arthritis-plus-hypothyroidism-ups-womens-cvd-risk
Denise Napoli

Mar 19th, 2012 - Women with both hypothyroidism and inflammatory arthritis have a nearly fourfold greater risk of developing heart disease, compared with controls. The finding adds to "sparse" data on the long-hypothesized association between hypothyroidism and in.

see more →